The pandemic has brought healthcare investment, R&D infrastructure and skills into sharp focus for all the economies of the Middle East. The sector is strategically important to most governments in the region, and is still likely to attract significant increases in spending relative to GDP over the next five years, albeit from a comparatively low base. But what are the medical priorities from country to country, beyond the coronavirus, and how will healthcare authorities, operators and suppliers meet those targets?
Join us for this special gathering of regional healthcare business leaders at which we will explore together the healthcare landscape. We will share the Economist Intelligence Unit's regional healthcare and pharmaceuticals spending forecasts, and discuss the innovations and technological breakthroughs that could change the provision and delivery of healthcare services in the Middle East, particularly for the chronic diseases that disproportionately affect the local populations.
We will also explore developments in health insurance, pricing and reimbursement.
The roundtable will take place at Zabeel House by Jumeirah in The Greens, Dubai. We are limiting numbers to 15 for this small, exclusive lunchtime event, to ensure we can practise safe social distancing while still benefiting from the face-to-face networking we have been missing for a while. So, if you would like to participate, please sign up now.
The highlights of this moderated discussion will be captured and - anonymously - used as the basis for a short paper on the topic at hand for the benefit of ECN members. A light lunch will be served during networking following the discussion.
12 noon: arrival and networking
12.15pm: roundtable starts
1.15pm: roundtable finishes and networking lunch
Please note that this event is limited to senior-level executives and per invitation only. If you are not an existing member of The Economist Corporate Network, but would like to learn how you can attend our events, please contact us.